Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2025 Earnings Call Transcript
Operator: Good day, and welcome to the First Quarter 2025 Harvard Bioscience Inc Earnings Conference Call. All participants will be in a listen-only mode.
Harvard Bioscience Inc (HBIO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Harvey Partners Jeffrey Moskowitz | 2,187,500 | $1,238,125 | -19% | 0.14% |
| 2. | Royce & Associates Chuck Royce | 1,777,894 | $1,006,288 | -10% | 0.01% |
| 3. | Renaissance Technologies Jim Simons | 883,698 | $500,173 | +25% | 0% |
| 4. | Meros Investment Management Timothy Chatard | 794,680 | $449,789 | -3% | 0.26% |
| 5. | Citadel Investment Group Ken Griffin | 329,964 | $186,759 | +381% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.91 | 10,000 | $29,100.00 | 3,111,091 | 2024-06-13 | Filing | |
| $3.07 | 20,000 | $61,400.00 | 3,101,091 | 2024-06-06 | Filing | |
| $4.38 | 25,000 | $109,500.00 | 2,862,679 | 2023-08-17 | Filing | |
| $2.62 | 16,192 | $42,423.04 | 202,485 | 2023-03-15 | Filing | |
| $2.67 | 13,808 | $36,867.36 | 186,293 | 2023-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.02 | 48,175 | $386,363.50 | 2,091,725 | 2021-08-23 | Filing | |
| $7.14 | 24,312 | $173,587.68 | 2,279,778 | 2021-05-21 | Filing | |
| $7.03 | 14,876 | $104,578.28 | 2,279,778 | 2021-05-20 | Filing | |
| $7.17 | 39,188 | $280,977.96 | 2,279,778 | 2021-05-19 | Filing | |
| $7.41 | 39,188 | $290,383.08 | 2,279,788 | 2021-05-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,387,355 | $1,917,243 | 2.89% | |
| 2. | 2,820,462 | $1,596,382 | 0% | |
| 3. | 2,138,749 | $1,210,532 | 0% | |
| 4. | 1,527,894 | $864,788 | 0.04% | |
| 5. | 1,437,808 | $813,906 | 0% |
News See All
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Fourth Quarter 2024 Harvard Bioscience Earnings Conference Call. At this time, all participants are in listen-only mode.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Third Quarter 2024 Harvard Biosciences Inc. Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2024 Harvard Bioscience, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript
Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.10815 EPS, expectations were $0.02. Harvard Bioscience, Inc.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2023 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to Harvard Bioscience, Inc. Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by and welcome to the Harvard Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by and welcome to Harvard Bioscience's Second Quarter 2023 Earnings Call.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Harvard Bioscience First Quarter 2023 Earnings Conference Call. Please be advised that today's conference is being recorded.
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Harvard Bioscience Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
